References:
1. Allana SS, Kostantinis S, Rempakos A, Simsek B, Karacsonyi J, Alexandrou M, Choi JW, Alaswad K, Krestyaninov O, Khelimskii D, Gorgulu S, Davies R, Benton S, Karmpaliotis D, Jaffer FA, Khatri JJ, Poommipanit P, Azzalini L, Kearney K, Chandwaney R, Nicholson W, Jaber W, Rinfret S, Frizzell J, Patel T, Jefferson B, Aygul N, Rangan BV, Brilakis ES. The Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Interventions: Technical Analysis and Procedural Outcomes. JACC Cardiovasc Interv. 2023 Nov 27;16(22):2748-2762.1.
2. Boden WE, O’Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators Impact of optimal medical therapy with or without Percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol. 2009 :1;104(1):1-4.
3. Stergiopoulos K, Boden WE, Hartigan P, Möbius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med. 2014 Feb 1;174(2):232-40
4. Kim MH, Mitsudo K, Jin CD, Kim TH, Cho YR, Park JS, Park K, Park TH, Serebruany V. Long-term clinical outcomes after successful and failed recanalization to native chronic Total occlusion: Insights from the Busan chronic Total occlusion (B-CTO) Registry. Cardiovasc Revasc Med. 2016 Jun;17(4):229-32.
5. Nathan, Allistair et al. “Percutaneous Coronary Intervention of Chronic Total Occlusion Associated with Higher Inpatient Mortality and Complications Compared With Non-CTO Lesions.” The American journal of medicine vol. 136,10 (2023): 994-999.
6. Movahed MR. Significant Downplay and Underreporting of Adverse Events in Patients Who Underwent Percutaneous Coronary Intervention of Chronic Total Occlusions. Am J Cardiol. 2023, 210;317
7. Movahed MR. It is time to have better oversite and accountability in performing too many not indicated percutaneous coronary interventions in patients with chronic total occlusions. Int J Cardiol. 2019 Mar 1;278:38-39.